Harvard’s Dan Peer Discusses Targeted siRNA Delivery In Vivo

Peer, along with colleagues at Harvard’s Immune Diseases Institute, recently published data showing how a delivery approach incorporating integrin and antibodies could be used to knock down a target in difficult-to-transfect leukocytes in vivo.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.